To prevent worsening of chronic obstructive pulmonary disease (COPD) and its associated costs, identifying patients at high risk of a first severe exacerbation is critical. A risk model for first ...
The new framework, which classifies the severity of exacerbations of COPD based on three key factors was developed by the ...
ELK CITY, Idaho--(BUSINESS WIRE)--Therapeutic Solutions International (TSOI) announced today new data and filing of a patent covering the discovery that JadiCell therapeutic activity in a model of ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A regional ...
A European consortium of researchers has developed a new decision making framework for health professionals which they hope ...
In a recent study published in the EClinicalMedicine, a group of researchers developed and validated a Chronic Obstructive Pulmonary Disease (COPD) (a progressive lung condition that causes breathing ...
Visualization of attention maps from the residual attention networks for the inspiratory convolutional neural network (I-CNN) and expiratory convolutional neural network (E-CNN) models. Attention maps ...
Patients with chronic obstructive pulmonary disease (COPD) that is in a state of disease stability (DS) have fewer exacerbations and lower mortality, according to study findings published in Chest.
Researchers from Shenyang Pharmaceutical University have discovered novel β2-adrenoceptor (β2-AR) agonists for the treatment of chronic obstructive pulmonary disease (COPD).
Chronic obstructive pulmonary disease (COPD) is a long-term lung condition that causes inflammation and lung damage. Lifestyle changes such as an anti-inflammatory diet and supplements can help manage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback